3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived...

Details 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived... 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived...

2005-01-11

2005-01-11

Raymond, Richard L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S190000, C546S200000, C548S427000, C548S305100, C514S411000, C514S387000, C544S372000

Reexamination Certificate

active

06841552

ABSTRACT:
Compounds of the formula:are disclosed as ligands for neuropeptide Y receptors and as such are useful in the treatment of obesity and disorders of the central nervous system.

REFERENCES:
patent: 97 19682 (1997-06-01), None
patent: 97 20823 (1997-06-01), None
patent: 98 35957 (1998-08-01), None
patent: 99 55667 (1999-11-01), None
patent: 00 20376 (2000-04-01), None
McNally et al. N-(Sulfonamido)alkyl[tetrahydro-1H-benzo[e]indol-2-yl]amines: Potent Antagonists of Human Neuropeptide Y Y5 Receptor Mar. 2000.*
McNall, James J. et al: “N- (Sulfonamidoalkyl) (tetrahydro-1H-benz'e!indol-2-yl) amines: potent antagonists of human neuropeptide Y Y5 receptor” Bioorg. Med. Chen. Lett. (2000), 10(3), 213-216 XP004188819 the whole document

Affiliated with

Also associated with

Rating

3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3367599